#1 Clinical Trials Search in Europe

Levamisole Hydrochloride

Levamisole Hydrochloride, originally developed as an anthelmintic medication, has shown promise in treating a variety of medical conditions. This article explores the ongoing clinical trials investigating the efficacy and safety of Levamisole Hydrochloride in diseases such as aplastic anemia, nephrotic syndrome, hepatocellular carcinoma, and parasitic infections. These trials aim to evaluate the drug’s potential as an immunomodulator and its ability to improve patient outcomes in different therapeutic areas.

Table of Contents

What is Levamisole Hydrochloride?

Levamisole Hydrochloride, also known simply as levamisole, is a medication that has been used for various medical purposes. It was originally developed as an anthelmintic drug, which means it was used to treat parasitic worm infections in humans and animals[1]. However, over time, researchers have discovered that levamisole has other potential uses due to its effects on the immune system.

Medical Uses

Levamisole has been studied and used for several medical conditions:

  • Aplastic Anemia: This is a condition where the body stops producing enough new blood cells. Levamisole is being investigated as part of a combination therapy for non-severe aplastic anemia[2].
  • Nephrotic Syndrome: This is a kidney disorder that causes the body to excrete too much protein in the urine. Levamisole is being studied as a treatment to maintain remission in children with steroid-sensitive nephrotic syndrome[3].
  • Cancer Treatment: Some studies are exploring the use of levamisole in combination with other drugs for treating advanced cancers, such as intrahepatic cholangiocarcinoma (a type of liver cancer) and hepatocellular carcinoma[4][5].
  • Parasitic Infections: Levamisole is being investigated for its potential in treating loiasis, a parasitic infection caused by the Loa loa worm[1].
  • Acne: Some research has looked at the use of levamisole in combination with antibiotics for treating inflammatory acne[6].
  • Immune System Modulation: Levamisole’s effects on the immune system have led to studies on its potential use in immune-related conditions and even as a preventive measure against infections like COVID-19[7].

Dosage and Administration

The dosage and administration of levamisole can vary depending on the condition being treated and the specific study or treatment protocol. Here are some examples from clinical trials:

  • For aplastic anemia: 150mg every other day[2]
  • For nephrotic syndrome in children: 2.5 mg/kg on alternate days, maximum 150mg[3]
  • For loiasis: 2.5 mg/kg for 3 or 5 days[1]
  • For cancer treatment: 150mg per day[4]
  • For immune modulation: 150 mg/day for two days per week[7]

It’s important to note that these dosages are from clinical trials and may not represent approved uses or dosages. Always follow your doctor’s instructions regarding medication use.

Side Effects and Safety

Like all medications, levamisole can cause side effects. The safety profile of levamisole is still being studied in many of these new applications. Some potential side effects and safety concerns include:

  • Gastrointestinal issues (nausea, vomiting, diarrhea)
  • Skin rashes or itching
  • Fatigue
  • Headache
  • Changes in blood cell counts (including a risk of agranulocytosis, a severe drop in white blood cells)[7]
  • Liver function changes

In clinical trials, researchers closely monitor patients for these and other potential side effects. It’s crucial to report any unusual symptoms to your healthcare provider if you’re taking levamisole.

Ongoing Research

Levamisole is currently the subject of several clinical trials exploring its potential in various medical conditions. These studies aim to better understand its efficacy, optimal dosing, and safety profile in different applications. Some areas of ongoing research include:

  • Its role in combination therapies for advanced liver cancers[4][5]
  • Its potential as an immune system modulator for preventing infections like COVID-19[7]
  • Its efficacy in treating parasitic infections like loiasis[1]
  • Its use in maintaining remission in nephrotic syndrome in children[3]

Conclusion

Levamisole Hydrochloride is a versatile drug that has shown potential in treating various medical conditions beyond its original use as an antiparasitic medication. While it shows promise in areas like cancer treatment, immune modulation, and certain autoimmune conditions, much of this research is still ongoing. As with any medication, the use of levamisole should always be under the guidance of a healthcare professional. Future research will help clarify its role in these various medical applications and provide more information about its efficacy and safety profile.

Condition Study Design Dosage Primary Outcome
Aplastic Anemia Randomized, Controlled 150mg every other day Improvement in blood cell counts
Nephrotic Syndrome Randomized, Double-blind, Placebo-controlled 2.5 mg/kg on alternate days Percentage of patients in remission at 12 months
Hepatocellular Carcinoma Randomized, Open-label 150mg daily Progression-free survival
Loiasis Randomized, Double-blind 2.5 mg/kg for 3 or 5 days Tolerance and efficacy in reducing microfilaremia
COVID-19 Prophylaxis Randomized, Open-label 150 mg/day for two days per week Incidence of COVID-19 infection

FAQ

  • What is Levamisole Hydrochloride? Levamisole Hydrochloride is a medication originally developed as an anthelmintic (anti-worm) drug. It has shown potential as an immunomodulator and is being studied for its effects in various medical conditions.
  • What medical conditions are being studied with Levamisole Hydrochloride? Clinical trials are investigating Levamisole Hydrochloride for conditions such as aplastic anemia, nephrotic syndrome, hepatocellular carcinoma, loiasis (a parasitic infection), and as an immune-prophylaxis against COVID-19 in healthcare workers.
  • How is Levamisole Hydrochloride administered in these trials? The administration of Levamisole Hydrochloride varies depending on the study. For example, in some trials, it is given orally at doses ranging from 2.5 mg/kg to 150 mg per day, either daily or on alternate days.
  • What are the potential benefits of Levamisole Hydrochloride? Potential benefits being studied include improved immune function, reduction in disease symptoms, maintenance of remission in certain conditions, and possible protective effects against infections.
  • Are there any side effects associated with Levamisole Hydrochloride? As with any medication, there can be side effects. The clinical trials are monitoring for adverse events, which may include gastrointestinal issues, changes in blood cell counts, and other potential effects. The safety profile is being carefully evaluated in each study.

Ongoing Clinical Trials on Levamisole Hydrochloride

  • Study of levamisole and prednisolone combination to prevent nephrotic syndrome relapse in children aged 2-16 years with first episode of steroid-sensitive disease

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Aplastic Anemia: A rare but serious blood disorder in which the body stops producing enough new blood cells.
  • Nephrotic Syndrome: A kidney disorder that causes the body to excrete too much protein in the urine.
  • Hepatocellular Carcinoma (HCC): The most common type of primary liver cancer, often occurring in people with chronic liver diseases.
  • Loiasis: A parasitic infection caused by the Loa loa worm, primarily found in Central Africa.
  • Immunomodulator: A substance that alters the immune system's response, either by enhancing or suppressing its function.
  • Microfilaremia: The presence of microfilariae (larval stages of certain parasitic worms) in the blood.
  • Steroid-Dependent: A condition where continued use of steroids is necessary to maintain remission or control of a disease.
  • Progression-Free Survival: The length of time during and after treatment that a patient lives with the disease but it does not get worse.
  • Overall Survival: The length of time from either the date of diagnosis or the start of treatment that patients are still alive.
  • Adverse Event: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.

References

  1. https://clinicaltrials.gov/study/NCT06252961
  2. https://clinicaltrials.gov/study/NCT03218657
  3. https://clinicaltrials.gov/study/NCT02818738
  4. https://clinicaltrials.gov/study/NCT03940378
  5. https://clinicaltrials.gov/study/NCT04611373
  6. https://clinicaltrials.gov/study/NCT01348321
  7. https://clinicaltrials.gov/study/NCT04360122